Chronic Obstructive Pulmonary Disease - Medicare Access (Medicare patients only)


Closed Funds

This fund is temporarily closed to new patients due to lack of sufficient funding. Please continue to visit our Disease Funds page often, as replenished funds reopen as quickly as possible. If you currently have a grant with HealthWell, your grant will remain active for the entire 12 month grant cycle or until you have exhausted your allocated grant amount, whichever comes first. You can continue to use your pharmacy card or submit requests for reimbursements during your designated grant cycle.

Fund Type


Maximum Award Level


Pharmacy Card Fund


Minimum Copay
Reimbursement Amount

Minimum Copay Reimbursement Amount

We encourage you to please use your HealthWell pharmacy card for any applicable charges as possible.


Minimum Premium
Reimbursement Amount

Minimum Premium Reimbursement Amount

We encourage you to please submit monthly reimbursement claims (even if your premium is paid on a bi-weekly basis).


Household Income Limit

500% of the Federal Poverty Level
(adjusted for household size and high
cost of living areas)

Fund Alerts

Sign up for email or text/call alerts to receive instant notifications.

Treatments Covered

  • Acetadote
  • Acetylcysteine
  • Acetylcysteine Novaplus
  • Aclidinium Bromide
  • Adoxa
  • Adoxa Pak 1/150
  • Advair Diskus 100/50
  • Advair Diskus 250/50
  • Advair Diskus 500/50
  • Albuterol Sulfate
  • Alkindi Sprinkle
  • Alpha-1-proteinase Inhibitor
  • Amerinet Choice Cetriaxone
  • Amerinet Choice Ciprofloxacin
  • Aminophylline
  • Aminophylline Anhydrous
  • Aminophylline Novaplus
  • Amoxicillin
  • Amoxicillin Trihydrate
  • Ampicillin
  • Ampicillin And Sulbactam
  • Ampicillin And Sulbactam Novaplus
  • Anoro Ellipta
  • Aralast Np
  • Arformoterol Tartrate
  • Arunity Ellipta
  • Atrovent Hfa
  • Augmentin
  • Avelox
  • Avelox Iv
  • Avidoxy
  • Azasite
  • Azithromycin
  • Azithromycin 1% In Klarity
  • Azithromycin Avpak
  • Azithromycin Dihydrate
  • Azithromycin Novaplus
  • Bactrim
  • Beclomethasone (oral Inhalation)
  • Beclomethasone Diproprionate
  • Benzonatate
  • Bevespi Aerosphere
  • Breo Ellipta
  • Breyna 160/4.5
  • Breyna 80/4.5
  • Breztri Aerosphere
  • Breztri Aerosphere Institutional Pack
  • Brovana
  • Budesonide-formoterol Fumarate
  • Cefaclor
  • Cefdinir
  • Cefixime
  • Cefotaxime
  • Cefotaxime Sodium
  • Cefpodoxime
  • Cefpodoxime Proxetil
  • Cefprozil
  • Ceftriaxone
  • Ceftriaxone Novaplus
  • Ceftriaxone Sodium
  • Ceftriaxone/dextrose
  • Cefuroxime
  • Cefuroxime Axetil
  • Cefuroxime Sodium
  • Cipro
  • Cipro Iv
  • Ciprofloxacin
  • Ciprofloxacin Hcl
  • Ciprofloxacin In Dextrose
  • Ciprofloxacin In Dextrose Novaplus
  • Ciprofloxacin Novaplus
  • Clarithromycin
  • Clarithromycin Avpak
  • Clavulanate Potassium
  • Combivent Respimat
  • Cortef
  • Cuvposa
  • Daliresp
  • Dartisla Odt
  • Decadron
  • Dexabliss 11-day Dose Pack
  • Dexamethasone
  • Dexamethasone Intensol
  • Dexamethasone Micronized
  • Dexamethasone Therapy Pack
  • Dextenza
  • Dexycu
  • Dopram
  • Doxapram Hydrochloride
  • Doxycycline
  • Doxycycline Avpak
  • Doxycycline Monohydrate
  • Dry
  • Duaklir Pressair
  • Dulera
  • Dupilimab
  • Dupixent Pen
  • Dupixent Pfs
  • Dxevo
  • Elixophyllin
  • Ery-tab
  • Erygel
  • Erythromycin
  • Flonase Sensimist
  • Floxin Otic
  • Fluticasone Furoate/vilanterol Ellipta
  • Formoterol Fumarate
  • Formoterol Fumarate Dihydrate
  • Glycate
  • Glycopyrrolate
  • Glycopyrrolate Novaplus
  • Glyrx-pf
  • Gnc Nac 600
  • Healthtrust Glycopyrrolate
  • Hemady
  • Hidex
  • Hydrocortisone
  • Hydrocortisone Avpak
  • Incruse Ellipta
  • Ipratropium Bromide
  • Isoproterenol Hydrochloride
  • Levalbuterol
  • Levalbuterol Hcl
  • Levofloxacin
  • Levofloxacin Hemihydrate
  • Lonhala Magnair
  • Magnesium Ulfate (iv)
  • Mason Natural Nac
  • Maxidex
  • Metaproterenol Sulfate
  • Methylprednisolone Sodium Succinate
  • Millipred
  • Mometasone-formoterol
  • Moxatag
  • Moxifloxacin Hcl
  • Moxifloxacin Hcl Avpak
  • N-acetyl-l-cysteine
  • Nac
  • Ocuflox
  • Ofloxacin
  • Olodaterol
  • Oracea
  • Orapred Odt
  • Otiprio
  • Ozurdex
  • Perforomist
  • Potassium Iodide
  • Predisolone Anhydrous
  • Prednisolone
  • Prednisolone Micronized
  • Prednisolone Sodium Phosphate
  • Prednisone
  • Prednisone Anhydrous
  • Prednisone Intensol
  • Premierpro Magnesium Sulfate (iv)
  • Premierpro Rx Acetylcysteine
  • Premierpro Rx Ampicillin-sulbactam
  • Premierpro Rx Azithromycin
  • Premierpro Rx Ceftriaxone
  • Premierpro Rx Glycopyrrolate
  • Proair Digihaler With Emodule
  • Proair Respiclick
  • Prolastin-c
  • Proventil Hfa
  • Pulmicort Flexhaler
  • Pulmicort Respules
  • Qnasl
  • Qvar Redihaler
  • Rayos
  • Revefenacin
  • Robinul
  • Robinul Forte
  • Roflumilast
  • Salmeterol Xinafoate
  • Serevent Diskus
  • Simplist Glycopyrrolate
  • Smz-tmp
  • Smz-tmp Concentrate
  • Smz-tmp Ds
  • Solu-medrol
  • Solu-medrol Novaplus
  • Spiriva Handihaler
  • Spiriva Respimat
  • Spiriva Respimat Institutional Pack 10act
  • Spiriva Respimat Institutional Pack 28act
  • Sski
  • Stiolto Respimat
  • Stiolto Respimat Institutional Pack 10act
  • Stiolto Respimat Institutional Pack 28act
  • Striverdi Respimat
  • Sulfamethoxazole/trimethoprim Avpak
  • Sulfamethoxazole/trimetoprim Novaplus
  • Suprax
  • Symbicort 160/4.5
  • Symbicort 80/4.5
  • Taperdex
  • Taperdex 6-day
  • Taperdex 7-day
  • Targadox
  • Terbutaline
  • Terbutaline Sulfate
  • Terbutaline Sulfate Novaplus
  • Theo-24
  • Theophylline
  • Theophylline Anhydrous
  • Tiotropium Bromide
  • Trelegy Ellipta
  • Tudorza Pressair
  • Umeclidinium
  • Unasyn
  • Ventolin Hfa
  • Vibramycin Monohydrate
  • Vigamox
  • Wixela Inhub
  • Xopenex
  • Yupelri
  • Zcort 7-day
  • Zemaira
  • Zithromax
  • Zithromax Tri-pak
  • Zithromax Z-pak
  • Zonatuss
  • Zoryve

Fund Definition

Assistance with the prescription drugs and biologics used in the treatment of chronic obstructive pulmonary disease.

Grant Utilization

HealthWell estimates that patients use an average of $2,500 during their 12-month grant period for this disease area.

Consider Premium Assistance

Under this fund, HealthWell can assist with premium costs. Medicare supplemental policies can help with cost shares related to many aspects of your health care. Using a HealthWell grant to cover premiums may be a better option than treatment-specific cost shares.

Do I Qualify?

HealthWell bases eligibility on an individual’s medical, financial and insurance situation. To qualify for HealthWell’s assistance, applicants must meet the following eligibility requirements:

  • Please make sure that HealthWell currently has a fund for your diagnosis/indication and that your medication is covered under that fund by visiting our Disease Funds listing. If we do not have a fund that currently covers your diagnosis, please check back as we frequently open and reopen programs as funding becomes available. The Foundation is able to help patients receiving treatment for indications for which we currently have an open fund. We can only assist with medications that have been prescribed to treat the disease/covered diagnosis. You will be asked to provide the Foundation with the patient’s diagnosis, which must be verified by a physician, nurse practitioner, or physician assistant’s signature. The patient must receive treatment in the United States.

  • This is a Medicare Access Fund. In order to qualify for assistance through this fund, you must have Medicare. The Foundation will refer patients without Medicare to other programs, such as manufacturer patient assistance programs.

  • HealthWell assists individuals with incomes up to 300-500% of the Federal Poverty Level. The Foundation also considers the number in a household and cost of living in a particular city or state. If you believe you qualify for assistance, you may begin the application process here.
  • If you are receiving treatment in the U.S. and have met the eligibility criteria as listed, you are ready to apply! Please note that you will be asked to provide a Social Security Number in order to create a grant. This information is gathered to eliminate duplicate applications and is kept secure and confidential.

About Chronic Obstructive Pulmonary Disease

COPD describes chronic lung diseases including emphysema (damage to the air sacs) and chronic bronchitis (damage to the bronchial tubes), which are characterized by breathlessness. COPD can progress for years without noticeable shortness of breath. Symptoms of COPD include increased shortness of breath, frequent coughing, wheezing, tightness in the chest, and unusual tiredness. Currently, COPD is an incurable disease, but treatments are available to help patients breathe better and improve their quality of life. COPD affects an estimated 30 million Americans, many of whom are undiagnosed.

Additional Educational Resources

You may also visit our Resource List to view other copayment organizations that may provide assistance.